The Anti-Aging Compound Spermidine Has a Dark Side in Old T Cells
Spermidine is widely promoted as an anti-aging polyamine, but a new mouse-derived cell study found it can sabotage a specific group of old immune cells. In senescence-like CD49d- CD8+ T cells, it cut mitochondrial respiration, depleted antioxidant reserves, and fragmented mitochondria, while neighboring CD49d+ cells were untouched. Cells from young mice responded differently, which makes age a key variable. This is preclinical work, not evidence of harm in humans, but it challenges the idea that spermidine helps every aging cell. Here's what the paper found and what it does and doesn't mean for you.
Urolithin A Shifted Aging T Cells in 4 Weeks. Here's the Catch
A randomized trial in Nature Aging found that four weeks of urolithin A shifted the immune profile of healthy middle-aged adults. It expanded naive-like CD8+ T cells and boosted their fat-burning capacity. But the headline number is small: a 0.5 percentage point change. The study ran only 4 weeks in 50 people, measured biomarkers rather than infections, and was funded by the maker of Mitopure. Here is what the data show, what they don't, and who might want to pay attention.